Article ID Journal Published Year Pages File Type
8719479 The Journal of Emergency Medicine 2018 8 Pages PDF
Abstract
No new studies published between 2010 and 2016 meaningfully reduced uncertainty regarding our understanding of the benefits and harms of intravenous rtPA for AIS. Discussions regarding benefit and harm should occur for patients, and risk prediction scores may facilitate the conversation.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Emergency Medicine
Preview
Intravenous Recombinant Tissue Plasminogen Activator and Ischemic Stroke: Focused Update of 2010 Clinical Practice Advisory From the American Academy of Emergency Medicine
Authors
, , , , , , , , ,